182 related articles for article (PubMed ID: 9660988)
1. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Abe S; Teraguchi S; Hayasawa H; Yamaguchi H
Antimicrob Agents Chemother; 1998 Jul; 42(7):1587-91. PubMed ID: 9660988
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
[TBL] [Abstract][Full Text] [Related]
3. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
[TBL] [Abstract][Full Text] [Related]
4. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
[TBL] [Abstract][Full Text] [Related]
5. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis and dimorphism of azole-susceptible and resistant Candida albicans isolates.
Costa CR; Hasimoto e Souza LK; Ataídes FS; Ferri PH; Costa MP; Fernanades Ode F; Silva Mdo R
Rev Soc Bras Med Trop; 2011; 44(6):740-4. PubMed ID: 22094708
[TBL] [Abstract][Full Text] [Related]
7. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
[TBL] [Abstract][Full Text] [Related]
8. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
9.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.
Fernandes KE; Weeks K; Carter DA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094132
[TBL] [Abstract][Full Text] [Related]
11. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
Oz Y; Akşit F; Kiraz N; Kiremitçi A
Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
[TBL] [Abstract][Full Text] [Related]
12. Activity of voriconazole against Candida albicans and Candida krusei isolated since 1984.
Lee JK; Peters D; Obias AA; Noskin GA; Peterson LR
Int J Antimicrob Agents; 2000 Nov; 16(3):205-9. PubMed ID: 11091037
[TBL] [Abstract][Full Text] [Related]
13. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.
Fung-Tomc JC; White TC; Minassian B; Huczko E; Bonner DP
Diagn Microbiol Infect Dis; 1999 Oct; 35(2):163-7. PubMed ID: 10579098
[TBL] [Abstract][Full Text] [Related]
14. Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Król J; Nawrot U; Bartoszewicz M
J Mycol Med; 2018 Jun; 28(2):327-331. PubMed ID: 29605543
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of propyl gallate-azole drug combination against fluconazole- and itraconazole-resistant Candida albicans strains.
D'Auria FD; Tecca M; Strippoli R; Simonetti N
Lett Appl Microbiol; 2001 Apr; 32(4):220-3. PubMed ID: 11298929
[TBL] [Abstract][Full Text] [Related]
16. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Jpn J Cancer Res; 1997 Feb; 88(2):184-90. PubMed ID: 9119747
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
18. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans.
Ha KC; White TC
Antimicrob Agents Chemother; 1999 Apr; 43(4):763-8. PubMed ID: 10103178
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.
Hitchcock CA; Barrett-Bee KJ; Russell NJ
J Med Vet Mycol; 1987 Oct; 25(5):329-33. PubMed ID: 3323450
[TBL] [Abstract][Full Text] [Related]
20. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
Sanati H; Belanger P; Fratti R; Ghannoum M
Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]